Production Operation Specialist II, External Manufacturing
Posted on: 9 Jan 2021
Cambridge, MA
Job Description
Job Description
The Production Operations Specialist maintains day-to-day Oracle production activities and works closely with the CMO Virtual Plant Teams to maintain systems and production timelines.
* Execute external production-related transactions in Oracle in a timely and accurate manner
* Generate purchase orders and perform invoice reconciliation
* Ensure production readiness (e.g. authorizations-to-manufacture)
* Create and update production batches in alignment with production planning (updated due dates, planned dates, and actual dates for production and release steps)
* Align proactively with CMO Virtual Plant Teams regarding ongoing production, priority batches and production challenges
* Leads or supports continuous improvement projects, metrics reporting, process documentation and training.
Qualifications
* Minimally BA/BS in Supply Chain Management, Business Administration, Quality, Engineering or similar education with 1-2 years of experience required
* Technical user level skills with IT systems
* ERP systems such as Oracle or SAP
* Microsoft Office (Excel, PowerPoint, SharePoint)
* Strong analytical and communication skills
* Strong team player with ability to work in cross functional teams
* Good English skills in speaking and writing
* Experience within an international and controlled environment preferred
* Project Management experience preferred
Additional Information
The Production Operations Specialist is part of the Production Operations Team within the External Manufacturing organization and is responsible for operational production management related to Contract Manufacturing Organizations (CMOs).
Biogen
Cambridge, MA
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis (MS); SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; and IMRALDI, an adalimumab biosimilar referencing HUMIRA. In addition, the company offers RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for the treatment of primary progressive MS and relapsing MS, and other anti-CD20 therapies.
Further, it is involved in developing BIIB098, Opicinumab, and BIIB061 for MS and neuroimmunology; Aducanumab, Elenbecestat, BAN2401, BIIB092, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB092 and BIIB054 for treating Parkinson's disease and movement disorders; BIIB067, BIIB078, and BIIB110 to treat neuromuscular disorders; BIIB093, TMS-007, and Natalizumab to treat acute neurology; BIIB104 for treating neurocognitive disorders; BIIB074 and BIIB095 for pain; and Dapirolzumab pegol, BG00011, and BIIB059 for treating other diseases, which are under various stages of development.
The company offers products through its sales force and marketing groups. Biogen Inc. has collaboration agreements with Genentech, Inc., Eisai Co., Ltd., Alkermes Pharma Ireland Limited, Bristol-Myers Squibb Company, Acorda Therapeutics, Inc., AbbVie Inc., C4 Therapeutics, University of Pennsylvania, Applied Genetic Technologies Corporation, and others. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
-
IndustryBiotechnology
-
No. of Employees7,800
-
Website
-
Jobs Posted445
